目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Procedure
Market segments
Comparison by Procedure
Immunodiagnostics - Market size and forecast 2020-2025
NAT - Market size and forecast 2020-2025
Market opportunity by Procedure

Market Segmentation by Diseases
Market segments
Comparison by Diseases
Hepatitis B - Market size and forecast 2020-2025
Hepatitis C - Market size and forecast 2020-2025
Market opportunity by Diseases

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Abbott Laboratories
bioMerieux SA
Danaher Corp.
DiaSorin SpA
Enzo Biochem Inc.
F. Hoffmann-La Roche Ltd.
PerkinElmer Inc.
QIAGEN N.V
Quest Diagnostics Inc.
Siemens Healthineers AG

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent market
10: Market characteristics
11: Offerings of vendors included in the market definition
12: Market segments
13: Global - Market size and forecast 2020 - 2025 ($ million)
14: Global market: Year-over-year growth 2020 - 2025 (%)
15: Five forces analysis 2020 & 2025
16: Bargaining power of buyers
17: Bargaining power of suppliers
18: Threat of new entrants
19: Threat of substitutes
20: Threat of rivalry
21: Market condition - Five forces 2020
22: Procedure - Market share 2020-2025 (%)
23: Comparison by Procedure
24: Immunodiagnostics - Market size and forecast 2020-2025 ($ million)
25: Immunodiagnostics - Year-over-year growth 2020-2025 (%)
26: NAT - Market size and forecast 2020-2025 ($ million)
27: NAT - Year-over-year growth 2020-2025 (%)
28: Market opportunity by Procedure
29: Diseases - Market share 2020-2025 (%)
30: Comparison by Diseases
31: Hepatitis B - Market size and forecast 2020-2025 ($ million)
32: Hepatitis B - Year-over-year growth 2020-2025 (%)
33: Hepatitis C - Market size and forecast 2020-2025 ($ million)
34: Hepatitis C - Year-over-year growth 2020-2025 (%)
35: Market opportunity by Diseases
36: Customer landscape
37: Market share By Geographical Landscape 2020-2025 (%)
38: Geographic comparison
39: North America - Market size and forecast 2020-2025 ($ million)
40: North America - Year-over-year growth 2020-2025 (%)
41: Europe - Market size and forecast 2020-2025 ($ million)
42: Europe - Year-over-year growth 2020-2025 (%)
43: Asia - Market size and forecast 2020-2025 ($ million)
44: Asia - Year-over-year growth 2020-2025 (%)
45: ROW - Market size and forecast 2020-2025 ($ million)
46: ROW - Year-over-year growth 2020-2025 (%)
47: Key leading countries
48: Market opportunity By Geographical Landscape ($ million)
49: Impact of drivers and challenges
50: Vendor landscape
51: Landscape disruption
52: Industry risks
53: Vendors covered
54: Market positioning of vendors
55: Abbott Laboratories - Overview
56: Abbott Laboratories - Business segments
57: Abbott Laboratories - Key offerings
58: Abbott Laboratories - Key customers
59: Abbott Laboratories - Segment focus
60: bioMerieux SA - Overview
61: bioMerieux SA - Product and service
62: bioMerieux SA - Key offerings
63: bioMerieux SA - Key customers
64: bioMerieux SA - Segment focus
65: Danaher Corp. - Overview
66: Danaher Corp. - Business segments
67: Danaher Corp. - Key offerings
68: Danaher Corp. - Key customers
69: Danaher Corp. - Segment focus
70: DiaSorin SpA - Overview
71: DiaSorin SpA - Business segments
72: DiaSorin SpA - Key offerings
73: DiaSorin SpA - Key customers
74: DiaSorin SpA - Segment focus
75: Enzo Biochem Inc. - Overview
76: Enzo Biochem Inc. - Business segments
77: Enzo Biochem Inc. - Key offerings
78: Enzo Biochem Inc. - Key customers
79: Enzo Biochem Inc. - Segment focus
80: F. Hoffmann-La Roche Ltd. - Overview
81: F. Hoffmann-La Roche Ltd. - Business segments
82: F. Hoffmann-La Roche Ltd. - Key offerings
83: F. Hoffmann-La Roche Ltd. - Key customers
84: F. Hoffmann-La Roche Ltd. - Segment focus
85: PerkinElmer Inc. - Overview
86: PerkinElmer Inc. - Business segments
87: PerkinElmer Inc. - Key offerings
88: PerkinElmer Inc. - Key customers
89: PerkinElmer Inc. - Segment focus
90: QIAGEN N.V - Overview
91: QIAGEN N.V - Product and service
92: QIAGEN N.V - Key offerings
93: QIAGEN N.V - Key customers
94: QIAGEN N.V - Segment focus
95: Quest Diagnostics Inc. - Overview
96: Quest Diagnostics Inc. - Business segments
97: Quest Diagnostics Inc. - Key offerings
98: Quest Diagnostics Inc. - Key customers
99: Quest Diagnostics Inc. - Segment focus
100: Siemens Healthineers AG - Overview
101: Siemens Healthineers AG - Business segments
102: Siemens Healthineers AG - Key offerings
103: Siemens Healthineers AG - Key customers
104: Siemens Healthineers AG - Segment focus
105: Currency conversion rates for US$
106: Research Methodology
107: Validation techniques employed for market sizing
108: Information sources
109: List of abbreviations